Intranasal administration of BDNF for treatment of primary headaches

WO2025202172A1PCT designated stage Publication Date: 2025-10-02DOMPE FARMACEUTICI SPA
1 Cites 0 Cited by

Patent Information

Application Number
PCT/EP2025/058078
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-03-26
Filing Date
2025-03-25
Publication Date
2025-10-02

Smart Images

  • Figure IMGF000005_0001
    Figure IMGF000005_0001
  • Figure IMGF000011_0001
    Figure IMGF000011_0001
  • Figure IMGF000012_0001
    Figure IMGF000012_0001
Patent Text Reader

Abstract

The present invention relates to brain derived nerve factor (BDNF) for use in the acute or preventive treatment of cluster headache or migraine attacks in a subject, wherein said BDNF is administered intranasally to said subject.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Intranasal administration of BDNF for the treatment of sensorineural hearing loss

    WO2024028483A1